Exploiting HPV-induced carcinogenesis for a rational drug development in cervical cancer.
Nogueira-Rodrigues A, Melo AC, Werutsky G, Garces AH, Ferreira CG.
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)
Novel targeted agents and combinations have become available in multiple lines of treatment for human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC). In this context, alternatives to the lapatinib (L) and capecitabine (C) regimen, evaluating L combined with other cytotoxic drugs, are warranted.
Progress and remaining challenges for cancer control in Latin America and the Caribbean
Martínez-Mesa J, Werutsky G, Campani RB, Wehrmeister FC, Barrios CH.
Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil
Pablo Moura Barrios, Marcio Debiasi, Gilberto Lopes, Carlos H. BarriosOctober 2016 Volume 11, Issue 10, Supplement, Page S215 Full link: https://www.jto.org/article/S1556-0864(16)30782-1/fulltext
The Global Conduct of Cancer Clinical Trials: Challenges and Opportunities
Carlos H. Barrios, MD, Gustavo Werutsky, MD, and Jeovany Martinez-Mesa, MD, PhD
In Reply to Chang and colleagues
Christine Pfund, PhD, Christine A. Sorkness, PharmD, Angela Byars-Winston, PhD, and Stephen B. Thomas, PhDDOI: 10.1097/ACM.0000000000000638 Full link: https://journals.lww.com/academicmedicine/Fulltext/2015/03000/In_Reply_to_Chang_and_colleagues.5.aspx
Progress and remaining challenges for cancer control in Latin America and the Caribbean
Kathrin Strasser-Weippl, Yanin Chavarri-Guerra, Cynthia Villarreal-Garza, Brittany L Bychkovsky, Marcio Debiasi, Pedro E R Liedke, Enrique Soto-Perez-de-Celis, Don Dizon, Eduardo Cazap, Gilberto de Lima Lopes Jr, Diego Touya, Jo?o Soares Nunes, Jessica St Louis, Caroline Vail, Alexandra Bukowski, Pier Ramos-Elias, Karla Unger-Saldaña, Denise Froes Brandao, Mayra E Ferreyra, Silvana Luciani, Angelica Nogueira-Rodrigues, Aknar Freire de Carvalho Calabrich, Marcela G Del Carmen, Jose Alejandro Rauh-Hain, Kathleen Schmeler, Raúl Sala, Paul E Goss DOI: Lancet Oncol 2015; 16: 1405-38 Full link: http://www.thelancet.com/commissions/latin-america
Global Epidemiology of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
Gustavo Werutsky, M. Debiasi, F.H.D. Sampaio, P.R.S. Nunes Filho, G.D.L. Lopes Júnior